Literature DB >> 27838393

Mutation spectrum of NF1 gene in Italian patients with neurofibromatosis type 1 using Ion Torrent PGM™ platform.

Francesco Calì1, Valeria Chiavetta2, Giuseppa Ruggeri2, Maria Piccione3, Angelo Selicorni4, Daniela Palazzo3, Maria Bonsignore5, Anna Cereda6, Maurizio Elia7, Pinella Failla7, Maria Grazia Figura7, Agata Fiumara8, Silvia Maitz9, Giuseppa Maria Luana Mandarà10, Teresa Mattina8, Alda Ragalmuto2, Corrado Romano7, Martino Ruggieri8, Roberto Salluzzo2, Antonino Saporoso5, Carmelo Schepis7, Giovanni Sorge8, Maria Spanò5, Gaetano Tortorella5, Valentino Romano11.   

Abstract

Neurofibromatosis type 1 (NF1) is caused by mutations of the NF1 gene and is one of the most common human autosomal dominant disorders. The patient shows different signs on the skin and other organs from early childhood. The best known are six or more café au lait spots, axillary or inguinal freckling, increased risk of developing benign nerve sheath tumours and plexiform neurofibromas. Mutation detection is complex, due to the large gene size, the large variety of mutations and the presence of pseudogenes. Using Ion Torrent PGM™ Platform, 73 mutations were identified in 79 NF1 Italian patients, 51% of which turned out to be novel mutations. Pathogenic status of each variant was classified using "American College of Medical Genetics and Genomics" guidelines criteria, thus enabling the classification of 96% of the variants identified as being pathogenic. The use of Next Generation Sequencing has proven to be effective as for costs, and time for analysis, and it allowed us to identify a patient with NF1 mosaicism. Furthermore, we designed a new approach aimed to quantify the mosaicism percentage using electropherogram of capillary electrophoresis performed on Sanger method.
Copyright © 2016 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Legius's syndrome; Mosaicism; Neurofibromatosis type 1; Next generation sequencing

Mesh:

Substances:

Year:  2016        PMID: 27838393     DOI: 10.1016/j.ejmg.2016.11.001

Source DB:  PubMed          Journal:  Eur J Med Genet        ISSN: 1769-7212            Impact factor:   2.708


  10 in total

1.  Phenotype categorization of neurofibromatosis type I and correlation to NF1 mutation types.

Authors:  Eungu Kang; Yoon-Myung Kim; Go Hun Seo; Arum Oh; Hee Mang Yoon; Young-Shin Ra; Eun Key Kim; Heyry Kim; Sun-Hee Heo; Gu-Hwan Kim; Mark J Osborn; Jakub Tolar; Han-Wook Yoo; Beom Hee Lee
Journal:  J Hum Genet       Date:  2019-11-28       Impact factor: 3.172

2.  Dealing with Pseudogenes in Molecular Diagnostics in the Next Generation Sequencing Era.

Authors:  Kathleen B M Claes; Toon Rosseel; Kim De Leeneer
Journal:  Methods Mol Biol       Date:  2021

3.  Novel c.C2254T (p.Q752*) mutation in ZFYVE26 (SPG15) gene in a patient with hereditary spastic paraparesis.

Authors:  Mirella Vinci; Marco Fchera; Sebastiano Antonino Musumeci; Francesco Cali; Girolamo Aurelio Vitello
Journal:  J Genet       Date:  2018-12       Impact factor: 1.166

4.  The cryo-EM structure of the human neurofibromin dimer reveals the molecular basis for neurofibromatosis type 1.

Authors:  Christopher J Lupton; Charles Bayly-Jones; Laura D'Andrea; Cheng Huang; Ralf B Schittenhelm; Hari Venugopal; James C Whisstock; Michelle L Halls; Andrew M Ellisdon
Journal:  Nat Struct Mol Biol       Date:  2021-12-09       Impact factor: 15.369

5.  Hybridization Capture-Based Next-Generation Sequencing to Evaluate Coding Sequence and Deep Intronic Mutations in the NF1 Gene.

Authors:  Karin Soares Cunha; Nathalia Silva Oliveira; Anna Karoline Fausto; Carolina Cruz de Souza; Audrey Gros; Thomas Bandres; Yamina Idrissi; Jean-Philippe Merlio; Rodrigo Soares de Moura Neto; Rosane Silva; Mauro Geller; David Cappellen
Journal:  Genes (Basel)       Date:  2016-12-17       Impact factor: 4.096

6.  Accurate Classification of NF1 Gene Variants in 84 Italian Patients with Neurofibromatosis Type 1.

Authors:  Alessandro Stella; Patrizia Lastella; Daria Carmela Loconte; Nenad Bukvic; Dora Varvara; Margherita Patruno; Rosanna Bagnulo; Rosaura Lovaglio; Nicola Bartolomeo; Gabriella Serio; Nicoletta Resta
Journal:  Genes (Basel)       Date:  2018-04-17       Impact factor: 4.096

7.  Simultaneous Detection of NF1, SPRED1, LZTR1, and NF2 Gene Mutations by Targeted NGS in an Italian Cohort of Suspected NF1 Patients.

Authors:  Donatella Bianchessi; Maria Cristina Ibba; Veronica Saletti; Stefania Blasa; Tiziana Langella; Rosina Paterra; Giulia Anna Cagnoli; Giulia Melloni; Giulietta Scuvera; Federica Natacci; Claudia Cesaretti; Gaetano Finocchiaro; Marica Eoli
Journal:  Genes (Basel)       Date:  2020-06-19       Impact factor: 4.096

8.  Risk of Optic Pathway Glioma in Neurofibromatosis Type 1: No Evidence of Genotype-Phenotype Correlations in A Large Independent Cohort.

Authors:  Giulia Melloni; Marica Eoli; Claudia Cesaretti; Donatella Bianchessi; Maria Cristina Ibba; Silvia Esposito; Giulietta Scuvera; Guido Morcaldi; Roberto Micheli; Elena Piozzi; Sabrina Avignone; Luisa Chiapparini; Chiara Pantaleoni; Federica Natacci; Gaetano Finocchiaro; Veronica Saletti
Journal:  Cancers (Basel)       Date:  2019-11-21       Impact factor: 6.639

9.  Genotype-Phenotype Correlations in Neurofibromatosis Type 1: Identification of Novel and Recurrent NF1 Gene Variants and Correlations with Neurocognitive Phenotype.

Authors:  Filomena Napolitano; Milena Dell'Aquila; Chiara Terracciano; Giuseppina Franzese; Maria Teresa Gentile; Giulio Piluso; Claudia Santoro; Davide Colavito; Anna Patanè; Paolo De Blasiis; Simone Sampaolo; Simona Paladino; Mariarosa Anna Beatrice Melone
Journal:  Genes (Basel)       Date:  2022-06-23       Impact factor: 4.141

10.  Confocal Microscopy Predicts the Risk of Recurrence and Malignant Transformation of Mucocutaneous Neurofibromas in NF-1: An Observational Study.

Authors:  Giuseppe Giudice; Giorgio Favia; Angela Tempesta; Luisa Limongelli; Michelangelo Vestita
Journal:  Dermatol Res Pract       Date:  2018-09-09
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.